Global Microarray Market Size to Exceed USD 10.48 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global Microarray Market Size Expected to Grow from USD 5.39 Billion in 2023 to USD 10.48 Billion by 2033, at a CAGR of 6.88% during the forecast period 2023-2033.
Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Microarray Market Size, Share, and COVID-19 Impact Analysis, By Product (Consumables, Software, Instruments), By Type (DNA, Protein, Other), By Application (Research, Drug Discovery, Disease Diagnostics), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
The microarray market is the industry that is engaged in developing, producing, and marketing microarray technologies to be applied for the analysis of gene expression, diagnosis of diseases, drug development, and biomarker discovery. Microarrays provide a means for high-throughput DNA, RNA, and protein analysis, facilitating scientists to examine genetic differences, epigenetics, and protein-protein interactions. Moreover, the microarray market is stimulated by genomics, personalized medicine, and biomarker discovery. Growing demand for cancer diagnosis, drug discovery, and genetic testing drives growth. Increasing investments in biotechnology research, increasing uses in disease diagnostics, and technical advances in high-throughput screening also drive market growth. Increasing use of microarray-based research in pharmaceuticals and healthcare adds to market potential. However, the high prices of microarray technologies, the complexity involved in data analysis, and the increasing popularity of next-generation sequencing (NGS) inhibit market expansion. Moreover, regulatory issues and low reproducibility in certain applications limit general acceptance.
The consumables segment accounted for the largest share of the global microarray market in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
On the basis of product, the global microarray market is divided into consumables, software, and instruments. Among these, the consumables segment accounted for the largest share of the global microarray market in 2023 and is anticipated to grow at a significant CAGR during the forecast period. This is because of their repeated use in repeated experiments, ongoing studies, and clinical diagnostics. Repeated utilization of microarray slides, reagents, and chips in genomics and proteomics applications result in constant usage, rendering consumables the leading segment in the microarray market.
The DNA segment accounted for a substantial share of the global microarray market in 2023 and is anticipated to grow at a rapid pace during the projected period.
On the basis of the type, the global microarray market is divided into DNA, protein, and other. Among these, the DNA segment accounted for a substantial share of the global microarray market in 2023 and is anticipated to grow at a rapid pace during the projected period. This is because of their extensive applications in gene expression analysis, genetic variation research, and disease diagnosis. Growing applications in personalized medicine, cancer studies, and drug discovery, as well as technological advancements in genomics, also propel the market dominance of DNA microarrays.
The disease diagnostics segment accounted for the largest share of the global microarray market in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
On the basis of application, the global microarray market is divided research, drug discovery, and disease diagnostics. Among these, the disease diagnostics segment accounted for the largest share of the global microarray market in 2023 and is anticipated to grow at a significant CAGR during the forecast period. This is because of their increasing application in cancer diagnosis, genetic disease screening, and infectious disease identification. The increased demand for personalized medicine, biomarker identification, and early disease diagnosis also enhances the stronghold of microarray technology in clinical diagnostics and healthcare industries.
North America is projected to hold the largest share of the global microarray market over the projected period.
North America is projected to hold the largest share of the global microarray market over the projected period. This is powered by robust healthcare infrastructure, intense biotech research, and high genomic technology adoption. The U.S. dominates the market with huge investments in personalized medicine, cancer studies, and drug discovery, supported by key players and research institutions.
Asia Pacific is expected to grow at the fastest CAGR of the global microarray market during the projected period. This is spurred by growing biotechnology research, healthcare investments, and demand for genetic testing. China, India, and Japan are leading in precision medicine, cancer diagnosis, and drug discovery, backed by government support and growing healthcare infrastructure.
Company Profiling
Major vendors in the global microarray market are microarrays Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Illumina, Inc., Thermo Fisher Scientific Inc., PerkinElmer, Merck KGaA, Danaher Corporation, GE Healthcare, Arrayit Corporation, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In January 2024, Thermo Fisher Scientific launched the Pangenomix Array, a novel genomic tool aimed at accelerating the investigation of genetic variations in different populations. The advanced array offers extensive coverage of human genetic diversity, enabling more precise genetic research and targeted medicine.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global microarray market based on the below-mentioned segments:
Global Microarray Market, By Product
Global Microarray Market, By Type
- Liquid
- Tablet
- Powder
- Softgels
Global Microarray Market, By Application
- Research
- Drug Discovery
- Disease Diagnostics
Global Microarray Market, By Regional
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa